financetom
DXLG
financetom
/
Consumer Discretionary
/
DXLG
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Destination XL Group, Inc.DXLG
USD
-0.100 (-8.85%)
Jun 18, 2025, 4:00 PM - At close
USD
+0.020 (1.95%)
Jun 18, 2025, 5:32 PM EDT - Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
55.43M
Revenue (ttm)
457.06M
Net Income (ttm)
-2.68M
Shares Out
53.82M
EPS (ttm)
-0.05
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
1,034,183
Open
1.120
Previous Close
1.130
Day's Range
1.000 - 1.130
52-Week Range
0.896 - 3.930
Beta
0.97
Analysts
Strong Buy
Price Target
2.50 (+142.72%)
Earnings Date
May 29, 2025
Description >

Destination XL Group, Inc., together with its subsidiaries, operates as a specialty retailer of big and tall men's clothing and shoes in the United States and Canada.

Its stores offer sportswear and dresswear; fashion-neutral items, including jeans, casual slacks, T-shirts, polo shirts, dress shirts, and suit separates; and casual clothing.

It also provides tailored-related separates, blazers, dress slacks, dress shirts, and suits; and vintage-screen T-shirts and wovens under various private labels.

The company offers its products under the trade names of Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets.

The company was formerly known as Casual Male Retail Group, Inc. and changed its name to Destination XL Group, Inc. in February 2013.

Destination XL Group, Inc. was incorporated in 1976 and is headquartered in Canton, Massachusetts.

Latest News >
GSK Says European Medicine Agency Committee Issues Positive Recommendation for Menveo Single-Vial Presentation
GSK Says European Medicine Agency Committee Issues Positive Recommendation for Menveo Single-Vial Presentation
Sep 24, 2024
07:16 AM EDT, 09/24/2024 (MT Newswires) -- GSK (GSK) said Tuesday the European Medicine Agency's Committee for Medicinal Products for Human Use has recommended approval for use of a single-vial, fully liquid presentation of Menveo vaccine against invasive meningococcal disease. The single-vial presentation, if approved, will be licensed for immunization of children from two years of age, adolescents, and adults,...
Nokia, ZCorum Sign Deal to develop DOCSIS Provisioning Adapter
Nokia, ZCorum Sign Deal to develop DOCSIS Provisioning Adapter
Sep 24, 2024
07:33 AM EDT, 09/24/2024 (MT Newswires) -- Nokia ( NOK ) said Tuesday that it has signed an agreement with ZCorum, a provider of broadband diagnostics and managed services, to develop a DOCSIS Provisioning Adapter application for cable-to-fiber transition. Nokia ( NOK ) said the application is intended to provide cable operators to connect the DOCSIS-based management system with its...
Denison, Foremost Both Up in US Pre-Market on $30 Million Option Agreement
Denison, Foremost Both Up in US Pre-Market on $30 Million Option Agreement
Sep 24, 2024
07:46 AM EDT, 09/24/2024 (MT Newswires) -- Denison Mines ( DNN ) said Tuesday that it signed an option agreement with a Nasdaq-listed company to be renamed Foremost Clean Energy (FAT.CN), granting Foremost an option to acquire up to 70% of Denison's interest in 10 uranium exploration properties. Following the news, Denison's share price was up 1.7% to US$1.80 in...
FrontView REIT aims to raise up to $277 mln in US IPO
FrontView REIT aims to raise up to $277 mln in US IPO
Sep 24, 2024
Sept 24 (Reuters) - FrontView REIT, which invests in properties in prominent locations facing high-traffic roads, aims to raise as much as $277.2 million in its initial public offering in the United States, the real estate investment trust said on Tuesday. The Dallas, Texas-based company - which had a portfolio of 278 properties across the United States with a 98.9%...
Copyright 2023-2025 - www.financetom.com All Rights Reserved